• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

取代 N-亚硝基-N-苄基甲胺致突变性的定量构效关系:对致癌性的可能影响。

Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.

作者信息

Singer G M, Andrews A W, Guo S M

出版信息

J Med Chem. 1986 Jan;29(1):40-4. doi: 10.1021/jm00151a006.

DOI:10.1021/jm00151a006
PMID:3510299
Abstract

The relative mutagenicities of substituted N-nitroso-N-benzylmethylamines have been reexamined from a quantitative structure-activity relationship point of view. Most of the compounds were mutagenic toward Salmonella typhimurium TA 1535 with Aroclor-induced male hamster liver S9 activation. The dose-response data were subjected to a multiple linear regression equation calculated in a stepwise manner, which found that the differences in mutagenicities could be explained primarily by differences in the three-bond path molecular connectivity index, with smaller contributions from sigma and pi. Moreover, a polynomial regression analysis showed that the maximum mutagenicity could be explained by an optimal amount of electron withdrawal by the substituent which would cause a weakening, or activation, of the methylene C-H bond. The possible relevance of these observations to carcinogenesis is discussed.

摘要

从定量构效关系的角度重新审视了取代N-亚硝基-N-苄基甲胺的相对诱变性。大多数化合物在Aroclor诱导的雄性仓鼠肝S9激活下对鼠伤寒沙门氏菌TA 1535具有诱变性。将剂量反应数据代入逐步计算的多元线性回归方程,发现诱变性的差异主要可以由三键路径分子连接性指数的差异来解释,σ和π的贡献较小。此外,多项式回归分析表明,最大诱变性可以用取代基最佳吸电子量来解释,该吸电子量会导致亚甲基C-H键减弱或活化。讨论了这些观察结果与致癌作用的可能相关性。

相似文献

1
Quantitative structure-activity relationship of the mutagenicity of substituted N-nitroso-N-benzylmethylamines: possible implications for carcinogenicity.取代 N-亚硝基-N-苄基甲胺致突变性的定量构效关系:对致癌性的可能影响。
J Med Chem. 1986 Jan;29(1):40-4. doi: 10.1021/jm00151a006.
2
Mutagenicity and chemistry of N-nitroso-N-(p-substituted-benzyl)methylamines.N-亚硝基-N-(对-取代苄基)甲胺的致突变性与化学性质
J Med Chem. 1983 Mar;26(3):309-12. doi: 10.1021/jm00357a001.
3
Carcinogenicity and mutagenicity of N-nitroso compounds.N-亚硝基化合物的致癌性和致突变性。
Mol Toxicol. 1987 Jan-Mar;1(1):107-19.
4
Mutagenicity and synthesis of alpha-substituted N-nitrosamines: derivatives with dithiocarbamic acid.α-取代N-亚硝胺的致突变性与合成:二硫代氨基甲酸衍生物
Carcinogenesis. 1982;3(5):563-7. doi: 10.1093/carcin/3.5.563.
5
Biological activity of benzylating N-nitroso compounds. Models of activated N-nitrosomethylbenzylamine.苄基化N-亚硝基化合物的生物活性。活化的N-亚硝基甲基苄胺模型。
Carcinogenesis. 1983;4(7):867-71. doi: 10.1093/carcin/4.7.867.
6
Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.使用大鼠和仓鼠肝脏S9比较N-亚硝胺对鼠伤寒沙门氏菌TA100和大肠杆菌WP2 uvrA/pKM101的诱变性。
Gan. 1984 Jan;75(1):8-16.
7
Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.在沙门氏菌/微粒体试验中,一些决定肝脏蛋白质浓度以实现化学物质最佳诱变性的因素。
Mutat Res. 1979 Dec;63(2):245-58. doi: 10.1016/0027-5107(79)90057-5.
8
Re-evaluation of the effect of ellagic acid on dimethylnitrosamine mutagenicity.
Mutagenesis. 1989 Nov;4(6):453-5. doi: 10.1093/mutage/4.6.453.
9
Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.胞质溶胶对不同菌株沙门氏菌中N-亚硝基二甲胺、N-亚硝基甲基脲和α-乙酰氧基-N-亚硝基二甲胺诱导诱变的影响:N-亚硝基二甲胺产生不同最终诱变剂的证据
Carcinogenesis. 1993 May;14(5):1013-9. doi: 10.1093/carcin/14.5.1013.
10
Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR and TA98/1,8-DNP6.硝基呋喃在鼠伤寒沙门氏菌TA98、TA98NR和TA98/1,8 - DNP6中的致突变性。
Mutat Res. 1987 Sep;192(1):15-22. doi: 10.1016/0165-7992(87)90120-5.